Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies. |
|
|
|
|
|
|
Assess and provide updates of new molecular and immunological treatments being developed for these diseases. |
|
|
|
|
|
|
Describe the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia. |
|
|
|
|
|
|
Identify the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options. |
|
|
|
|
|
|